H-STAPPAHGV-OH

Rif. 3D-PP46486

Informazioni sul prodotto

• Nome: H-STAPPAHGV-OH
• Sinonimi: NH2-Ser-Thr-Ala-Pro-Pro-Ala-His-Gly-Val-OH

Descrizione

Peptide H-STAPPAHGV-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-STAPPAHGV-OH include the following: Efficient discovery of immune response targets by cyclical refinement of QSAR models of peptide binding V Brusic , K Bucci, C Schönbach , N Petrovsky - Journal of Molecular , 2001 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S1093326300000991 Induction of HLA-A2-restricted CTLs to the mucin 1 human breast cancer antigen. V Apostolopoulos , V Karanikas, JS Haurum - (Baltimore, Md.: 1950 , 1997 - journals.aai.orghttps://journals.aai.org/jimmunol/article-abstract/159/11/5211/30949 Getting into the groove: unusual features of peptide binding to MHC class I molecules and implications in vaccine design V Apostolopoulos , IF McKenzie, IA Wilson - Front Biosci, 2001 - article.imrpress.comhttps://article.imrpress.com/bri/Landmark/articles/pdf/LandmarkA683.pdf Vaccine Development Against Novel Breast Cancer Antigens V Apostolopoulos , I McKenzie - 2002 - apps.dtic.milhttps://apps.dtic.mil/sti/citations/tr/ADA409560 Anti-MUC1 antibodies react directly with MUC1 peptides presented by class I H2 and HLA molecules V Apostolopoulos , G Chelvanayagam - The Journal of , 1998 - journals.aai.orghttps://journals.aai.org/jimmunol/article/161/2/767/31120 Delivery of tumor associated antigens to antigen presenting cells using penetratin induces potent immune responses V Apostolopoulos , DS Pouniotis, PJ van Maanen - Vaccine, 2006 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0264410X06000569 Sequence-variant repeats of MUC1 show higher conformational flexibility, are less densely O-glycosylated and induce differential B lymphocyte responses S von Mensdorff-Pouilly, L Kinarsky, K Engelmann - , 2005 - academic.oup.comhttps://academic.oup.com/glycob/article-abstract/15/8/735/637686 Reactivity of natural and induced human antibodies to MUC1 mucin with MUC1 peptides and n-acetylgalactosamine (GalNAc) peptides S von Mensdorff-Pouilly, E Petrakou - Journal of Cancer, 2000 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/(SICI)1097-0215(20000601)86:5%3C702::AID-IJC16%3E3.0.CO;2-1 HUMORAL IMMUNE RESPONSES BY IMMUNIZATIONS WITH FULLY SYNTHETIC THREE-COMPONENT CANCER VACCINE CANDIDATES PS Thompson - SYNTHESIS AND IMMUNOTHERAPEUTIC STUDIES - getd.libs.uga.eduhttp://getd.libs.uga.edu/pdfs/thompson_pamela_s_201112_phd.pdf#page=142 MUC1-specific Cytotoxic T Lymphocytes Eradicate Tumors When Adoptively Transferred in Vivo P Mukherjee , AR Ginardi, TL Tinder, CJ Sterner - Clinical cancer , 2001 - AACRhttps://aacrjournals.org/clincancerres/article-abstract/7/3/848s/200197 Mice with spontaneous pancreatic cancer naturally develop MUC-1-specific CTLs that eradicate tumors when adoptively transferred P Mukherjee , AR Ginardi, CS Madsen - The Journal of , 2000 - journals.aai.orghttps://journals.aai.org/jimmunol/article/165/6/3451/69796 Tumour-associated antigenic peptides are present in the HLA class I ligandome of cancer cell line derived extracellular vesicles P Kumar , C Boyne, S Brown, A Qureshi, P Thorpe - , 2022 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1111/imm.13471 A central core structure in an antibody variable domain determines antigen specificity P Jirholt, L Strandberg, B Jansson - Protein , 2001 - academic.oup.comhttps://academic.oup.com/peds/article-abstract/14/1/67/1575510 Identification of HLA-A2-restricted T-cell epitopes derived from the MUC1 tumor antigen for broadly applicable vaccine therapies P Brossart, KS Heinrich, G Stuhler - Blood, The Journal , 1999 - ashpublications.orghttps://ashpublications.org/blood/article-abstract/93/12/4309/260963 Synthesis and immunological evaluation of a multicomponent cancer vaccine candidate containing a long MUC1 glycopeptide NT Supekar , V Lakshminarayanan - , 2018 - Wiley Online Libraryhttps://chemistry-europe.onlinelibrary.wiley.com/doi/abs/10.1002/cbic.201700424 STUDY ON THE EFFECT OF LINKERS IN MONOGLYCOSYLATED LMUC1-BASED MULTICOMPONENT CANCER VACCINE CANDIDATES. NT Supekar - SYNTHESIS AND IMMUNOLOGICAL EVALUATION OF - getd.libs.uga.eduhttps://getd.libs.uga.edu/pdfs/supekar_nitin_t_201612_phd.pdf#page=141 SYNTHESIS AND IMMUNOLOGICAL EVALUATION OF MONOGLYCOSYLATED FULL-LENGTH MUC1-BASED MULTICOMPONENT CANCER VACCINE NT Supekar - SYNTHESIS AND IMMUNOLOGICAL EVALUATION OF - getd.libs.uga.eduhttp://getd.libs.uga.edu/pdfs/supekar_nitin_t_201612_phd.pdf#page=80 Identification of an HLA-A11-restricted epitope from the tandem repeat domain of the epithelial tumor antigen mucin. N Domenech , RA Henderson , OJ Finn - Journal of immunology , 1995 - journals.aai.orghttps://journals.aai.org/jimmunol/article-abstract/155/10/4766/29001 Immunogenicity of a tripartite cell penetrating peptide containing a MUC1 variable number of tandem repeat (VNTR) and AT helper epitope N Brooks, J Hsu, S Esparon, D Pouniotis, GA Pietersz - Molecules, 2018 - mdpi.comhttps://www.mdpi.com/1420-3049/23/9/2233 Mucin-type O-glycosylation and its potential use in drug and vaccine development MA Tarp, H Clausen - Biochimica et Biophysica Acta (BBAhttps://www.sciencedirect.com/science/article/pii/S0304416507002164 Identification of three non-VNTR MUC1-derived HLA-A*0201-restricted T-cell epitopes that induce protective anti-tumor immunity in HLA-A2/Kb-transgenic mice LC Heukamp, SH van der Burg - journal of cancer, 2001 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/1097-0215(200002)9999:9999%3C::AID-IJC1051%3E3.0.CO;2-Z MUC1 peptide vaccination in patients with advanced pancreas or biliary tract cancer K Yamamoto, T Ueno, T Kawaoka, S Hazama - Anticancer , 2005 - ar.iiarjournals.orghttps://ar.iiarjournals.org/content/25/5/3575.short CG IOANNIDES, B. FISK, KR JEROME, B. CHESAK, T. IRIMURA JT WHARTON, OJ FINN - Ovarian Cancer 3, 2012 - books.google.comhttps://books.google.com/books?hl=en&lr=&id=mMQkBAAAQBAJ&oi=fnd&pg=PA317&dq=(%22NH2-Ser-Thr-Ala-Pro-Pro-Ala-His-Gly-Val-OH%22+OR+%22H-STAPPAHGV-OH%22+OR+%22STAPPAHGV%22)+AND+peptide&ots=X5M8t6Cp2g&sig=cdKQJyLAlV_P86oWpENGmUqCpXo Selection and characterization of MUC1-specific CD8+ T cells from MUC1 transgenic mice immunized with dendritic-carcinoma fusion cells J Gong, V Apostolopoulos , D Chen, H Chen - , 2000 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1046/j.1365-2567.2000.00101.x Context of MUC1 epitope: immunogenicity IS Quinlin, JS Burnside, KE Dombrowski - Oncology , 2007 - spandidos-publications.comhttps://www.spandidos-publications.com/or/17/2/453 substrate primary amino acid sequence on the activity of human UDP-N-acetylgalactosamine: polypeptide N-acetylgalactosaminyltransferase. Studies with I Nishimori, NR Johnson, SD Sanderson - Journal of Biological , 1994 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0021925817339819 A 16-mer peptide (RQIKIWFQNRRMKWKK) from antennapedia preferentially targets the Class I pathway GA Pietersz, W Li, V Apostolopoulos - Vaccine, 2001 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0264410X0000373X Presentation of MUC1 tumor antigen by class I MHC and CTL function correlate with the glycosylation state of the protein taken up by dendritic cells EM Hiltbold , MD Alter, P Ciborowski , OJ Finn - Cellular immunology, 1999 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0008874999915125 MUC1-specific cytotoxic T lymphocytes in cancer therapy: induction and challenge D Roulois, M Gregoire - BioMed research , 2013 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1155/2013/871936 Oxidized and reduced mannan mediated MUC1 DNA immunization induce effective anti-tumor responses CK Tang, KC Sheng, D Pouniotis, S Esparon, HY Son - Vaccine, 2008 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0264410X08005744 Ovarian tumour reactive cytotoxic T lymphocytes can recognize peptide determinants on polymorphic epithelial mucins Muc-1 CG Ioannides, B Fisk, KR Jerome , B Chesak, T Irimura - Ovarian Cancer 3, 1995 - Springerhttps://link.springer.com/chapter/10.1007/978-1-4757-0136-4_31 Rapid induction of primary human CD4+ and CD8+ T cell responses against cancer-associated MUC1 peptide epitopes. B Agrawal, MJ Krantz, MA Reddish - International , 1998 - academic.oup.comhttps://academic.oup.com/intimm/article-abstract/10/12/1907/744541 MUC1 immunobiology: from discovery to clinical applications AM Vlad , JC Kettel, NM Alajez , CA Carlos - Advances in , 2004 - books.google.comhttps://books.google.com/books?hl=en&lr=&id=Bc8PmpSIaUIC&oi=fnd&pg=PA249&dq=(%22NH2-Ser-Thr-Ala-Pro-Pro-Ala-His-Gly-Val-OH%22+OR+%22H-STAPPAHGV-OH%22+OR+%22STAPPAHGV%22)+AND+peptide&ots=QXOvRS5d5C&sig=2B1-87LX83Vbg5pRG_U4MAnoTAw Bridging innate and adaptive antitumor immunity targeting glycans A Pashov , B Monzavi-Karbassi - BioMed Research , 2010 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1155/2010/354068

• Marchio: Biosynth